Europe Organ-on-Chip Market Size, Share & Industry Trends Analysis Report By Type (Lung on chip, Heart on chip, Human on chip, Kidney on chip, Liver on chip, and Intestine on chip), By Country and Growth Forecast, 2022 - 2028

Europe Organ-on-Chip Market Size, Share & Industry Trends Analysis Report By Type (Lung on chip, Heart on chip, Human on chip, Kidney on chip, Liver on chip, and Intestine on chip), By Country and Growth Forecast, 2022 - 2028

The Europe Organ-on-Chip Market would witness market growth of 29.6% CAGR during the forecast period (2022-2028).

The convergence of labs-on-chips (LOCs) with cell biology has enabled the study of human physiology within an organ-specific setting, hence establishing a unique model of multicellular human organisms in vitro. Perhaps, one day, the use of animals in drug development and toxicity testing would be eliminated. Multiple publications assert that organ functions have been mapped onto this interface, however, this microfluidic application is still in its early stage.

The design and methodology of organs-on-chips will vary between different researchers. Therefore, the process of validating and optimizing these systems would likely be lengthy. Microfluidic devices have replicated a variety of organs, including the brain, heart, lung, kidney, liver, prostate, artery, skin, bone, and cartilage. In spite of this, creating viable artificial organs needs not just precise cellular manipulation, but also a thorough comprehension of the human body's fundamentally complex response to any event.

During testing, the isolation of organs is a common concern with organs-on-chips. The body is a complicated network of physiological processes, making it tough to imitate a single organ. Microfabrication, microelectronics, and microfluidics offer the possibility of properly simulating complex in vitro physiological reactions. The invention of organ chips has made it possible to examine the intricate pathophysiology of human viral infections. The liver chip platform, for instance, has enabled research into viral hepatitis.

European countries possess highly advanced healthcare and pharmaceutical industries. According to the International Trade Administration, Germany has the third largest market for medical technology in the world, and is by far the largest market in Europe, with twice the size of the market in France and three times that of Italy, the United Kingdom, and Spain. The German market for medical devices is one of the most lucrative in the world, accounting for around 25.6% of the overall European market.

The Germany market dominated the Europe Organ-on-Chip Market by Country in 2021; thereby, achieving a market value of $55,115.3 Thousands by 2028. The UK market is exhibiting a CAGR of 28.6% during (2022 - 2028). Additionally, The France market would experience a CAGR of 30.6% during (2022 - 2028).

Based on Type, the market is segmented into Lung on chip, Heart on chip, Human on chip, Kidney on chip, Liver on chip, and Intestine on chip. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AxoSim, Inc., Visikol, Inc., CN Bio Innovations Limited., Elveflow (Elvesys Group), Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc. and TARA Biosystems, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Lung on chip
  • Heart on chip
  • Human on chip
  • Kidney on chip
  • Liver on chip
  • Intestine on chip
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • AxoSim, Inc.
  • Visikol, Inc.
  • CN Bio Innovations Limited.
  • Elveflow (Elvesys Group)
  • Emulate, Inc.
  • Insphero AG,
  • Mimetas B.V.
  • Nortis Inc.
  • Organovo Holdings, Inc.
  • TARA Biosystems, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Organ-on-Chip Market, by Type
1.4.2 Europe Organ-on-Chip Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Organ-on-Chip Market by Type
3.1 Europe Lung on chip Market by Country
3.2 Europe Heart on chip Market by Country
3.3 Europe Human on chip Market by Country
3.4 Europe Kidney on chip Market by Country
3.5 Europe Liver on chip Market by Country
3.6 Europe Intestine on chip Market by Country
Chapter 4. Europe Organ-on-Chip Market by Country
4.1 Germany Organ-on-Chip Market
4.1.1 Germany Organ-on-Chip Market by Type
4.2 UK Organ-on-Chip Market
4.2.1 UK Organ-on-Chip Market by Type
4.3 France Organ-on-Chip Market
4.3.1 France Organ-on-Chip Market by Type
4.4 Russia Organ-on-Chip Market
4.4.1 Russia Organ-on-Chip Market by Type
4.5 Spain Organ-on-Chip Market
4.5.1 Spain Organ-on-Chip Market by Type
4.6 Italy Organ-on-Chip Market
4.6.1 Italy Organ-on-Chip Market by Type
4.7 Rest of Europe Organ-on-Chip Market
4.7.1 Rest of Europe Organ-on-Chip Market by Type
Chapter 5. Company Profiles
5.1 Visikol, Inc.
5.1.1 Company Overview
5.2 CN Bio Innovations Ltd.
5.2.1 Company Overview
5.2.2 Recent strategies and developments:
5.2.2.1 Product Launches and Product Expansions:
5.2.2.2 Geographical Expansions:
5.3 Elveflow (Elvesys Group)
5.3.1 Company Overview
5.4 Emulate, Inc.
5.4.1 Company Overview
5.4.2 Recent strategies and developments:
5.4.2.1 Product Launches and Product Expansions:
5.5 Insphero AG
5.5.1 Company Overview
5.6 Mimetas B.V.
5.6.1 Company Overview
5.6.2 Recent strategies and developments:
5.6.2.1 Partnerships, Collaborations, and Agreements:
5.6.2.2 Product Launches and Product Expansions:
5.7 Nortis Inc.
5.7.1 Company Overview
5.8 Organovo Holdings, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Research & Development Expenses
5.9 TARA Biosystems, Inc.
5.9.1 Company Overview
5.10. AxoSim, Inc.
5.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings